Class information for:
Level 1: CILNIDIPINE//BENIDIPINE//AZELNIDIPINE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
21976 398 30.9 83%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
11 3       ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION 130936
822 2             CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS//NIFEDIPINE 11902
21976 1                   CILNIDIPINE//BENIDIPINE//AZELNIDIPINE 398

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CILNIDIPINE authKW 4058356 18% 73% 72
2 BENIDIPINE authKW 2282798 14% 55% 54
3 AZELNIDIPINE authKW 2116422 10% 69% 40
4 CAS 91599 74 5 authKW 469915 2% 88% 7
5 L N TYPE CALCIUM CHANNEL BLOCKER authKW 460327 2% 100% 6
6 CAS 105979 17 7 authKW 230164 1% 100% 3
7 CONIEL R authKW 230164 1% 100% 3
8 SM 6586 authKW 230164 1% 100% 3
9 CALCIUM CHANNEL BLOCKERS authKW 186832 19% 3% 76
10 N TYPE CALCIUM CHANNEL authKW 160640 4% 12% 17

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Peripheral Vascular Diseases 4667 32% 0% 127
2 Pharmacology & Pharmacy 3021 51% 0% 202
3 Cardiac & Cardiovascular System 551 16% 0% 62
4 Chemistry, Medicinal 340 9% 0% 37
5 Urology & Nephrology 76 5% 0% 19
6 Medicine, Research & Experimental 12 3% 0% 13
7 Endocrinology & Metabolism 10 3% 0% 13
8 Chemistry, Multidisciplinary 2 5% 0% 19
9 Medicine, General & Internal 1 3% 0% 10
10 Physiology 1 2% 0% 6

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MED EDUC POPULAT BASED MED 102294 1% 67% 2
2 1258 HIROMACHI 76721 0% 100% 1
3 EVALUAT ANALYS DRUG INFORMAT 76721 0% 100% 1
4 HYPERTENS NEPHROL INTERNAL MED 76721 0% 100% 1
5 KLIN WESTFALI EN 76721 0% 100% 1
6 MED FRONTIER HLTH SCI ANTIAGING 76721 0% 100% 1
7 OFMINISTRY EDUC 76721 0% 100% 1
8 POST MKT SURVEILLANCE GRPCHOU KU 76721 0% 100% 1
9 RADIOIOSTOPE BASIC CLIN MED 76721 0% 100% 1
10 SANKYO BIOL S 76721 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HYPERTENSION RESEARCH 71413 12% 2% 48
2 CLINICAL AND EXPERIMENTAL HYPERTENSION 8662 4% 1% 15
3 JAPANESE JOURNAL OF PHARMACOLOGY 6307 5% 0% 19
4 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 5638 5% 0% 18
5 ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH 5245 3% 1% 12
6 HEART AND VESSELS 5093 3% 1% 11
7 JOURNAL OF PHARMACOLOGICAL SCIENCES 3974 3% 0% 11
8 JOURNAL OF HYPERTENSION 2276 4% 0% 17
9 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 2240 5% 0% 18
10 BIOLOGICAL & PHARMACEUTICAL BULLETIN 1990 4% 0% 15

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CILNIDIPINE 4058356 18% 73% 72 Search CILNIDIPINE Search CILNIDIPINE
2 BENIDIPINE 2282798 14% 55% 54 Search BENIDIPINE Search BENIDIPINE
3 AZELNIDIPINE 2116422 10% 69% 40 Search AZELNIDIPINE Search AZELNIDIPINE
4 CAS 91599 74 5 469915 2% 88% 7 Search CAS+91599+74+5 Search CAS+91599+74+5
5 L N TYPE CALCIUM CHANNEL BLOCKER 460327 2% 100% 6 Search L+N+TYPE+CALCIUM+CHANNEL+BLOCKER Search L+N+TYPE+CALCIUM+CHANNEL+BLOCKER
6 CAS 105979 17 7 230164 1% 100% 3 Search CAS+105979+17+7 Search CAS+105979+17+7
7 CONIEL R 230164 1% 100% 3 Search CONIEL+R Search CONIEL+R
8 SM 6586 230164 1% 100% 3 Search SM+6586 Search SM+6586
9 CALCIUM CHANNEL BLOCKERS 186832 19% 3% 76 Search CALCIUM+CHANNEL+BLOCKERS Search CALCIUM+CHANNEL+BLOCKERS
10 N TYPE CALCIUM CHANNEL 160640 4% 12% 17 Search N+TYPE+CALCIUM+CHANNEL Search N+TYPE+CALCIUM+CHANNEL

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 TAMARGO, J , RUILOPE, LM , (2016) INVESTIGATIONAL CALCIUM CHANNEL BLOCKERS FOR THE TREATMENT OF HYPERTENSION.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 25. ISSUE 11. P. 1295 -1309 68 42% 0
2 YAO, K , NAGASHIMA, K , MIKI, H , (2006) PHARMACOLOGICAL, PHARMACOKINETIC, AND CLINICAL PROPERTIES OF BENIDIPINE HYDROCHLORIDE, A NOVEL, LONG-ACTING CALCIUM CHANNEL BLOCKER.JOURNAL OF PHARMACOLOGICAL SCIENCES. VOL. 100. ISSUE 4. P. 243-261 53 56% 31
3 TAKAHARA, A , (2009) CILNIDIPINE: A NEW GENERATION CA2+ CHANNEL BLOCKER WITH INHIBITORY ACTION ON SYMPATHETIC NEUROTRANSMITTER RELEASE.CARDIOVASCULAR THERAPEUTICS. VOL. 27. ISSUE 2. P. 124 -139 49 43% 30
4 ARITOMI, S , KOGANEI, H , WAGATSUMA, H , MITSUI, A , OGAWA, T , NITTA, K , KONDA, T , (2010) THE N-TYPE AND L-TYPE CALCIUM CHANNEL BLOCKER CILNIDIPINE SUPPRESSES RENAL INJURY IN DAHL RATS FED A HIGH-SALT DIET.HEART AND VESSELS. VOL. 25. ISSUE 6. P. 549-555 18 69% 3
5 ARITOMI, S , KONDA, T , YOSHIMURA, M , (2012) L/N-TYPE CALCIUM CHANNEL BLOCKER SUPPRESSES REFLEX ALDOSTERONE PRODUCTION INDUCED BY ANTIHYPERTENSIVE ACTION.HEART AND VESSELS. VOL. 27. ISSUE 4. P. 419-423 18 62% 7
6 HATTA, T , TAKEDA, K , SHIOTSU, Y , SUGISHITA, C , ADACHI, T , KIMURA, T , SONOMURA, K , KUSABA, T , KISHIMIOTO, N , NARUMIYA, H , ET AL (2012) SWITCHING TO AN L/N-TYPE CALCIUM CHANNEL BLOCKER SHOWS RENOPROTECTIVE EFFECTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: THE KYOTO CILNIDIPINE STUDY.JOURNAL OF INTERNATIONAL MEDICAL RESEARCH. VOL. 40. ISSUE 4. P. 1417-1428 20 54% 4
7 KOIKE, Y , KAWABE, T , NISHIHARA, K , IWANE, N , HANO, T , (2015) CILNIDIPINE BUT NOT AMLODIPINE SUPPRESSES SYMPATHETIC ACTIVATION ELICITED BY ISOMETRIC EXERCISE IN HYPERTENSIVE PATIENTS.CLINICAL AND EXPERIMENTAL HYPERTENSION. VOL. 37. ISSUE 7. P. 531 -535 19 50% 2
8 FUKUMOTO, S , ISHIMURA, E , MOTOYAMA, K , MORIOKA, T , KIMOTO, E , WAKIKAWA, K , SHOJI, S , KOYAMA, H , SHOJI, T , EMOTO, M , ET AL (2012) ANTIALBUMINURIC ADVANTAGE OF CILNIDIPINE COMPARED WITH L-TYPE CALCIUM CHANNEL BLOCKERS IN TYPE 2 DIABETIC PATIENTS WITH NORMOALBUMINURIA AND MICROALBUMINURIA.DIABETES RESEARCH AND CLINICAL PRACTICE. VOL. 97. ISSUE 1. P. 91-98 13 76% 5
9 KONOSHITA, T , KAERIYAMA, S , URABE, M , NAKAYA, T , YAMADA, M , ICHIKAWA, M , YAMAMOTO, K , SATO, S , IMAGAWA, M , FUJII, M , ET AL (2016) ON THE TOP OF ARB N/L TYPE CA CHANNEL BLOCKER LEADS TO LESS ELEVATION OF ALDOSTERONE.BIOSCIENCE REPORTS. VOL. 36. ISSUE . P. - 18 51% 0
10 ABE, M , MARUYAMA, N , SUZUKI, H , INOSHITA, A , YOSHIDA, Y , OKADA, K , SOMA, M , (2013) L/N-TYPE CALCIUM CHANNEL BLOCKER CILNIDIPINE REDUCES PLASMA ALDOSTERONE, ALBUMINURIA, AND URINARY LIVER-TYPE FATTY ACID BINDING PROTEIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE.HEART AND VESSELS. VOL. 28. ISSUE 4. P. 480-489 22 44% 3

Classes with closest relation at Level 1


Rank Class id link
1 21385 AMLODIPINE//NIFEDIPINE GITS//MODERN APPROACH TO THE TREATMENT OF HYPERTENSION MATH TRIAL
2 12596 DESIALYLATED LOW DENSITY LIPOPROTEINS//CALCIUM ANTAGONISTS//INTRACELLULAR CHOLESTEROL ACCUMULATION
3 9931 MIBEFRADIL//T TYPE CALCIUM CHANNEL//T TYPE CA2 CHANNEL
4 29297 LERCANIDIPINE//LERCANIDIPINE HYDROCHLORIDE//CAS 132866 11 6
5 10759 LACIDIPINE//MEBUDIPINE//NIFEDIPINE
6 21605 POSTINFARCTION ARRHYTHMIAS//SPRINT STUDY GRP//CALCIUM CHANNEL BLOCKERS
7 4584 PROTEINURIA//ANGIOTENSIN RECEPTOR BLOCKER//DUAL BLOCKADE
8 35384 CD 832//PRANIDIPINE//KT 362
9 4492 DIHYDROPYRIDINE//SR 33557//BAY K 8644
10 3095 OMEGA CONOTOXIN GVIA//OMEGA AGATOXIN IVA//OMEGA CONOTOXIN

Go to start page